The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Emphysema Treatment Market Research Report 2024
Synopsis
Chronic obstructive pulmonary disease (COPD) is kind of lung disease which happen due to chronic obstruction of lung airflow that interferes with normal breathing and is not fully reversible.
The global Emphysema Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Emphysema Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Emphysema Treatment.
Report Scope
The Emphysema Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Emphysema Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Emphysema Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pulmonx
Bioxyne
Intrexon
Icure Pharmaceuticals
Kamada
Emphasys Medical
Pfizer
Olympus
BTG
PneumRx and Uptake Medical
Halozyme Therapeutics
Mariposa Health
Uptake Medical
Segment by Type
Centrilobular emphysema
Panlobular emphysema
Segment by Application
Hospital
Clinics
Surgical center
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Emphysema Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Chronic obstructive pulmonary disease (COPD) is kind of lung disease which happen due to chronic obstruction of lung airflow that interferes with normal breathing and is not fully reversible.
The global Emphysema Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Emphysema Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Emphysema Treatment.
Report Scope
The Emphysema Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Emphysema Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Emphysema Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pulmonx
Bioxyne
Intrexon
Icure Pharmaceuticals
Kamada
Emphasys Medical
Pfizer
Olympus
BTG
PneumRx and Uptake Medical
Halozyme Therapeutics
Mariposa Health
Uptake Medical
Segment by Type
Centrilobular emphysema
Panlobular emphysema
Segment by Application
Hospital
Clinics
Surgical center
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Emphysema Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Emphysema Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Centrilobular emphysema
1.2.3 Panlobular emphysema
1.3 Market by Application
1.3.1 Global Emphysema Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Surgical center
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Emphysema Treatment Market Perspective (2019-2030)
2.2 Emphysema Treatment Growth Trends by Region
2.2.1 Global Emphysema Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Emphysema Treatment Historic Market Size by Region (2019-2024)
2.2.3 Emphysema Treatment Forecasted Market Size by Region (2025-2030)
2.3 Emphysema Treatment Market Dynamics
2.3.1 Emphysema Treatment Industry Trends
2.3.2 Emphysema Treatment Market Drivers
2.3.3 Emphysema Treatment Market Challenges
2.3.4 Emphysema Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Emphysema Treatment Players by Revenue
3.1.1 Global Top Emphysema Treatment Players by Revenue (2019-2024)
3.1.2 Global Emphysema Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Emphysema Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Emphysema Treatment Revenue
3.4 Global Emphysema Treatment Market Concentration Ratio
3.4.1 Global Emphysema Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Emphysema Treatment Revenue in 2023
3.5 Emphysema Treatment Key Players Head office and Area Served
3.6 Key Players Emphysema Treatment Product Solution and Service
3.7 Date of Enter into Emphysema Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Emphysema Treatment Breakdown Data by Type
4.1 Global Emphysema Treatment Historic Market Size by Type (2019-2024)
4.2 Global Emphysema Treatment Forecasted Market Size by Type (2025-2030)
5 Emphysema Treatment Breakdown Data by Application
5.1 Global Emphysema Treatment Historic Market Size by Application (2019-2024)
5.2 Global Emphysema Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Emphysema Treatment Market Size (2019-2030)
6.2 North America Emphysema Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Emphysema Treatment Market Size by Country (2019-2024)
6.4 North America Emphysema Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Emphysema Treatment Market Size (2019-2030)
7.2 Europe Emphysema Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Emphysema Treatment Market Size by Country (2019-2024)
7.4 Europe Emphysema Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Emphysema Treatment Market Size (2019-2030)
8.2 Asia-Pacific Emphysema Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Emphysema Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Emphysema Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Emphysema Treatment Market Size (2019-2030)
9.2 Latin America Emphysema Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Emphysema Treatment Market Size by Country (2019-2024)
9.4 Latin America Emphysema Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Emphysema Treatment Market Size (2019-2030)
10.2 Middle East & Africa Emphysema Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Emphysema Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Emphysema Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pulmonx
11.1.1 Pulmonx Company Detail
11.1.2 Pulmonx Business Overview
11.1.3 Pulmonx Emphysema Treatment Introduction
11.1.4 Pulmonx Revenue in Emphysema Treatment Business (2019-2024)
11.1.5 Pulmonx Recent Development
11.2 Bioxyne
11.2.1 Bioxyne Company Detail
11.2.2 Bioxyne Business Overview
11.2.3 Bioxyne Emphysema Treatment Introduction
11.2.4 Bioxyne Revenue in Emphysema Treatment Business (2019-2024)
11.2.5 Bioxyne Recent Development
11.3 Intrexon
11.3.1 Intrexon Company Detail
11.3.2 Intrexon Business Overview
11.3.3 Intrexon Emphysema Treatment Introduction
11.3.4 Intrexon Revenue in Emphysema Treatment Business (2019-2024)
11.3.5 Intrexon Recent Development
11.4 Icure Pharmaceuticals
11.4.1 Icure Pharmaceuticals Company Detail
11.4.2 Icure Pharmaceuticals Business Overview
11.4.3 Icure Pharmaceuticals Emphysema Treatment Introduction
11.4.4 Icure Pharmaceuticals Revenue in Emphysema Treatment Business (2019-2024)
11.4.5 Icure Pharmaceuticals Recent Development
11.5 Kamada
11.5.1 Kamada Company Detail
11.5.2 Kamada Business Overview
11.5.3 Kamada Emphysema Treatment Introduction
11.5.4 Kamada Revenue in Emphysema Treatment Business (2019-2024)
11.5.5 Kamada Recent Development
11.6 Emphasys Medical
11.6.1 Emphasys Medical Company Detail
11.6.2 Emphasys Medical Business Overview
11.6.3 Emphasys Medical Emphysema Treatment Introduction
11.6.4 Emphasys Medical Revenue in Emphysema Treatment Business (2019-2024)
11.6.5 Emphasys Medical Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Emphysema Treatment Introduction
11.7.4 Pfizer Revenue in Emphysema Treatment Business (2019-2024)
11.7.5 Pfizer Recent Development
11.8 Olympus
11.8.1 Olympus Company Detail
11.8.2 Olympus Business Overview
11.8.3 Olympus Emphysema Treatment Introduction
11.8.4 Olympus Revenue in Emphysema Treatment Business (2019-2024)
11.8.5 Olympus Recent Development
11.9 BTG
11.9.1 BTG Company Detail
11.9.2 BTG Business Overview
11.9.3 BTG Emphysema Treatment Introduction
11.9.4 BTG Revenue in Emphysema Treatment Business (2019-2024)
11.9.5 BTG Recent Development
11.10 PneumRx and Uptake Medical
11.10.1 PneumRx and Uptake Medical Company Detail
11.10.2 PneumRx and Uptake Medical Business Overview
11.10.3 PneumRx and Uptake Medical Emphysema Treatment Introduction
11.10.4 PneumRx and Uptake Medical Revenue in Emphysema Treatment Business (2019-2024)
11.10.5 PneumRx and Uptake Medical Recent Development
11.11 Halozyme Therapeutics
11.11.1 Halozyme Therapeutics Company Detail
11.11.2 Halozyme Therapeutics Business Overview
11.11.3 Halozyme Therapeutics Emphysema Treatment Introduction
11.11.4 Halozyme Therapeutics Revenue in Emphysema Treatment Business (2019-2024)
11.11.5 Halozyme Therapeutics Recent Development
11.12 Mariposa Health
11.12.1 Mariposa Health Company Detail
11.12.2 Mariposa Health Business Overview
11.12.3 Mariposa Health Emphysema Treatment Introduction
11.12.4 Mariposa Health Revenue in Emphysema Treatment Business (2019-2024)
11.12.5 Mariposa Health Recent Development
11.13 Uptake Medical
11.13.1 Uptake Medical Company Detail
11.13.2 Uptake Medical Business Overview
11.13.3 Uptake Medical Emphysema Treatment Introduction
11.13.4 Uptake Medical Revenue in Emphysema Treatment Business (2019-2024)
11.13.5 Uptake Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
